ArticleOncogene2013

Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro.

M K Ki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.